Literature DB >> 28665463

Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.

Gianfranca Solinas1, Francesca Platini1, Maurizio Trivellato1, Carla Rigo1, Oscar Alabiso1,2, Alessandra S Galetto1,2.   

Abstract

INTRODUCTION: Patients with cancer need stable venous access using central vascular devices like central venous ports and peripherally inserted central catheters that can be used for a wide range of indications. Numerous flushing protocols exist including different frequencies for catheter locking to maintain catheter patency. The aim of this retrospective study was to evaluate the incidence of lumen occlusion of central venous ports in a group of adult cancer patients, adopting a policy of locking with normal saline every three months.
METHODS: This is a single-center retrospective observational study. During follow-up, we analyzed adult cancer patients who had undergone port insertion from January 1st, 2007 to August 31st, 2014. Flushing and locking were performed every three months with a syringe containing normal saline.
RESULTS: We collected data from 381 patients with ports inserted in subclavian vein (379 patients) and in the right jugular vein (2 patients). Locking was performed during 3-monthly follow-up visits. Median follow-up was 810 days (90-2700 days). Among 381 ports, 59 were removed; the reasons for removal were: end of use (45 cases), catheter rupture (9 cases), dislocation (3 cases) and catheter-related bloodstream infection (2 cases). We had no reports of lumen occlusion.
CONCLUSIONS: Our data suggest that locking ports with normal saline every three months is not associated with an increased risk of lumen occlusion.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28665463     DOI: 10.5301/jva.5000740

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  4 in total

1.  Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports.

Authors:  Pin-Li Chou; Jui-Ying Fu; Chia-Hui Cheng; Yen Chu; Ching-Feng Wu; Po-Jen Ko; Yun-Hen Liu; Ching-Yang Wu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.889

2.  Management of outpatient with totally implantable venous access Ports during the COVID-19 epidemic.

Authors:  Weipeng Yan; Chaoya Zhang; Chenggang Luo; Zilin Li
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

3.  Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments.

Authors:  Sang-Bo Oh; Kwonoh Park; Jae-Joon Kim; So-Yeon Oh; Ki-Sun Jung; Byung-Soo Park; Gyung-Mo Son; Hyun-Sung Kim; Dong-Hyun Kim; Hyuk-Jae Jung; Sang-Su Lee
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

4.  Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial.

Authors:  Melania Cia-Arriaza; Sandra Cabrera-Jaime; Rosario Cano-Soria; Mireia Manzano-Castro; Margarita Domínguez-Gómez; Dolores M Prieto-Arenas; Angeles Benito-Yagüe; Adela Sánchez-Martín; Cristina González-Alonso; Paz Fernández-Ortega
Journal:  Asia Pac J Oncol Nurs       Date:  2022-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.